CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., Nov. 29, 2021 (GLOBE NEWSWIRE) -- F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company dedicated to developing next generation bispecific immunotherapies to transform the lives of patients with cancer, today announced that it will host an R&D Day webinar on Monday, December 6, 2021, from 8:00 a.m. to 10:00 a.m. ET.
The 21st century pharmaceutical and biotech sector has come a long way from its roots in 19th century pharmacy. pharmaphorum looks at its evolution over the centuries.
marketdataanalytics.biz has published the latest report on the global Tiapride market. This report includes complete details about the Tiapride market. The plus point about this research study is that it includes the impact of COVID-19 to the Tiapride market. The data encapsulated within this research study includes historical data from 2015 to 2019 and the forecast from 2020 to 2026. COVID-19 has greatly impacted each and every market on the global platform. All the countries in the world are and is going to face economical crisis which will also leave imprints on the Tiapride market.
Drugmaker Century Pharmaceuticals Ltd has hired an investment bank as it seeks to raise fresh funds and give a full exit to its existing investor which put in money in the firm nine years ago, two …
A Vadodara-based export oriented company, Century Pharmaceuticals Ltd (CPL), is expanding and upgrading its plant according to USFDA specification in order to enter the US pharma market by 2007. The company is awaiting its USFDA certification. Century pharma is exploring a possibility of exporting erythromycin, an active pharmaceutical ingredients (API) to US.